Cargando…
Psoriasis: Comorbidities
Psoriasis has long been known as a disease with many complications, but was attributed to diet and obesity. However, in recent years, psoriasis itself has been recognized as a series of systemic inflammatory diseases, and that the cytokines involved can induce a variety of other diseases. Individual...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/ https://www.ncbi.nlm.nih.gov/pubmed/33763899 http://dx.doi.org/10.1111/1346-8138.15840 |
_version_ | 1783717373495214080 |
---|---|
author | Yamazaki, Fumikazu |
author_facet | Yamazaki, Fumikazu |
author_sort | Yamazaki, Fumikazu |
collection | PubMed |
description | Psoriasis has long been known as a disease with many complications, but was attributed to diet and obesity. However, in recent years, psoriasis itself has been recognized as a series of systemic inflammatory diseases, and that the cytokines involved can induce a variety of other diseases. Individuals with psoriasis were also found to have higher incidences of cerebral and cardiovascular diseases and a younger age at death compared to healthy individuals. However, no clear guidelines have been defined regarding how much vascular lesion testing should be performed in patients with psoriasis. In this report, I attempt to unravel the objective data on psoriasis and its complications from various reviews and reports, and introduce the impact of biologics, which are currently the main treatment for psoriasis, on cardiac vascular disease. |
format | Online Article Text |
id | pubmed-8252780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82527802021-07-12 Psoriasis: Comorbidities Yamazaki, Fumikazu J Dermatol Review Articles Psoriasis has long been known as a disease with many complications, but was attributed to diet and obesity. However, in recent years, psoriasis itself has been recognized as a series of systemic inflammatory diseases, and that the cytokines involved can induce a variety of other diseases. Individuals with psoriasis were also found to have higher incidences of cerebral and cardiovascular diseases and a younger age at death compared to healthy individuals. However, no clear guidelines have been defined regarding how much vascular lesion testing should be performed in patients with psoriasis. In this report, I attempt to unravel the objective data on psoriasis and its complications from various reviews and reports, and introduce the impact of biologics, which are currently the main treatment for psoriasis, on cardiac vascular disease. John Wiley and Sons Inc. 2021-03-25 2021-06 /pmc/articles/PMC8252780/ /pubmed/33763899 http://dx.doi.org/10.1111/1346-8138.15840 Text en © 2021 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Articles Yamazaki, Fumikazu Psoriasis: Comorbidities |
title | Psoriasis: Comorbidities |
title_full | Psoriasis: Comorbidities |
title_fullStr | Psoriasis: Comorbidities |
title_full_unstemmed | Psoriasis: Comorbidities |
title_short | Psoriasis: Comorbidities |
title_sort | psoriasis: comorbidities |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252780/ https://www.ncbi.nlm.nih.gov/pubmed/33763899 http://dx.doi.org/10.1111/1346-8138.15840 |
work_keys_str_mv | AT yamazakifumikazu psoriasiscomorbidities |